More information Year, Recipient ...
Awards
Year | Recipient | Lecture title |
1982 | Sir Mark Richmond | β-Lactamases: are they really important? |
1983 | F W O'Grady | Strategies for potentiating chemotherapy in severe sepsis: some experimental pointers. |
1984 | Sir Charles Stuart-Harris | Strategies of antiviral chemotherapy. |
1985 | Naomi Datta | Antidotes of bacteria to antibacterial drugs |
1986 | Sir Edward P Abraham | β-Lactamase antibiotics: motivation, science and luck in their past and future |
1987 | George N. Rolinson[3] | The influence of 6-aminopenicillanic acid on antibiotic development. |
1990 | Robert C. Moellering Jr[4][5] | The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. |
1991 | Denis Mitchison | Understanding the chemotherapy of tuberculosis - current problems. |
1999 | Alasdair Geddes | Infection in the 21st Century - and possible implications for therapy. |
2009 | Sir Richard Sykes | The evolution of antimicrobial resistance: a Darwinian perspective |
2011 | Brian Spratt[6] | My 40 years - from penicillin-binding proteins to molecular epidemiology. Given during the BSAC 40th anniversary scientific Spring Meeting |
2012 | Ian Chopra[7] | Discovery of anti-bacterial drugs in the twenty-first century |
2016 | John E. McGowan Jr[8] | The role of the healthcare epidemiologist in antimicrobial chemotherapy—a view from the USA |
2017 | Peter Hawkey[9] | Genes, guts and globalization |
2018 | David Livermore | The Black Swans of Resistance |
2019 | Laura Piddock | MDR efflux in Gram-negative bacteria—how understanding resistance led to a new tool for drug discovery |
Close